Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Literature
1.
Kramer N, Ramjith J, Shamley D (2019) Prevalence of shoulder morbidity after treatment for breast cancer in South Africa. Support Care Cancer 27(7):2591–2598CrossRef
2.
Iovino F, Gatta G, Auriemma PP, Dani L, Antoniol G, Barbarisi A (2019) Late shoulder-arm morbidity using ultrasound scalpel in axillary dissection for breast cancer: a retrospective analysis. J Surg Res 233:88–95CrossRef
3.
Verbelen H, Gebruers N, Eeckhout FM, Verlinden K, Tjalma W (2014) Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review. Breast Cancer Res Treat 144(1):21–31CrossRef
4.
Levangie PK, Drouin J (2009) Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat 116(1):1–15CrossRef
5.
Hidding JT, Beurskens CH, van der Wees PJ, van Laarhoven HW, Nijhuis-van der Sanden MW (2014) Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One 9(5):e96748CrossRef
Metadata
Title
Comments on “Prevalence of shoulder morbidity after treatment for breast Cancer in South Africa”
Author
Sibel Eyigör
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04990-z

Other articles of this Issue 3/2020

Supportive Care in Cancer 3/2020 Go to the issue

Original Article

Long-term prognosis of septic shock in cancer patients

Original Article

Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial

Original Article

Coping mechanisms for financial toxicity: a qualitative study of cancer patients’ experiences in Germany

Original Article

Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer

Letter to the Editor

Beliefs and ignorance: two enemies of supportive care in cancer

Original Article

Mind-body medicine use by women diagnosed with breast cancer: results of a nationally representative survey
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits